Abul Feilat R, Castiglioni F, Battaglia A, Dozio F, Zocchi G, Bisazza R
Chir Ital. 1980 Apr;32(2):413-22.
With regard to vesica tumors, a remarkable difficulty for the interpretation of statistical data is often given by the different classifications that the different authors use. Therefore we have reported a comparative table always for being faithful to what we wished at the beginning of this work that has be useful to the doctor above all by a clinical point of view. In synthesis all the Authors think that radiotherapy is not the elective treatment for tumors in O or A stage, while it can be efficient in the therapy of vesica neoplasies in B1, B2 and C stages. The most Authors seem less favourable to preoperating irradiation of tumor above all for the unexact intraoperating valuation of "staging" that is inevitable after this treatment. Postoperating radiotherapy (5000-6000 R in 20-30 days) can be more useful in the cases of incomplete surgical exeresis although there is the problem of possible radiolesions of eventual uretero-intestinal anastomosis let alone of intestine. In the end urethra tumors are sensitive to radiotherapy for their superficiality and excellent tolerance of membrum to radiations that permits also the giving of 6000-7000 R in 4-6 days.
关于膀胱肿瘤，不同作者采用的不同分类方法常常给统计数据的解读带来显著困难。因此，我们列出了一个对比表，始终忠实于我们在这项工作开始时所期望的，这尤其从临床角度对医生很有用。总之，所有作者都认为放射治疗不是O期或A期肿瘤的首选治疗方法，而在B1、B2和C期膀胱肿瘤的治疗中可能有效。大多数作者似乎不太赞成对肿瘤进行术前照射，尤其是因为这种治疗后不可避免地会出现手术中对“分期”的不准确评估。术后放射治疗（20 - 30天内给予5000 - 6000拉德）在手术切除不完全的情况下可能更有用，尽管存在最终输尿管 - 肠吻合口以及肠道可能出现放射性损伤的问题。最后，尿道肿瘤因其表浅性以及黏膜对辐射的耐受性良好而对放射治疗敏感，这也使得在4 - 6天内给予6000 - 7000拉德的照射成为可能。
